American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 3.
Kibble
Alexandra
A
Thomson Scientific, 77 Hatton Garden, London, EC1N 8JS, UK. alexandra.kibble@thomson.com
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D000077784:Axitinib; D000068258:Bevacizumab; D035843:Biomedical Research / Q000379:methods / Q000639:trends; D001943:Breast Neoplasms / Q000188:drug therapy; D000068818:Cetuximab; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000737:chemistry; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D007191:Indazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D008297:Male; D015394:Molecular Structure; D009369:Neoplasms / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D016896:Treatment Outcome; D000093542:Gemcitabine
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007093:Imidazoles; D007191:Indazoles; D009944:Organoplatinum Compounds; D010880:Piperidines; D011799:Quinazolines; D003841:Deoxycytidine; D000068258:Bevacizumab; C081294:satraplatin; D011239:Prednisolone; D000077784:Axitinib; D000068818:Cetuximab; C452423:vandetanib; D000093542:Gemcitabine